Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis
- PMID: 28413520
- PMCID: PMC5377569
- DOI: 10.3892/etm.2017.4137
Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis
Abstract
The present retrospective study aimed to investigate the prognostic factors for critically ill patients with an Acinetobacter baumannii (A. baumannii) infection. A total of 37 patients from the intensive care unit (ICU) were enrolled in the study. Data was collected from patients, including age, gender, ethnicity, A. baumannii infection status, concurrent infection status, prescribed antibiotics, Acute Physiology and Chronic Health Evaluation II (APACHE II) and sepsis-related organ failure assessment (SOFA) scores, procalcitonin level, site of infection, shock, sepsis and renal replacement therapy status. Univariate and multivariate analyses were performed to determine the prognostic factors for mortality. In total, 8 out of the 37 patients included in this trial did not survive, resulting in an ICU mortality rate of 21.6%. Univariate analysis indicated that, in comparison with the survival group, APACHE II and SOFA scores were significantly higher in the mortality group (P<0.002 and P<0.001, respectively). A larger number of patients with septic shock were detected in the mortality group in comparison with the survival group (n=4 and n=3, respectively), whereas a larger number of patients were infected with multidrug-resistant A. baumannii (MDRAB) in the survival group in comparison with the mortality group (51.9 and 14.3%, respectively). However, the prognosis was not significantly influenced by antibiotics administered, mixed infection or the site of infection. Multivariate analysis demonstrated that the APACHE II score was the only independent factor affecting the disease prognosis. Receiver operating characteristic curve analysis of the APACHE II score demonstrated that the area under the curve was 0.845±0.078. In patients with an APACHE II score of 15, the sensitivity and specificity predictions for mortality were 87.5% and 72.4%, respectively. The APACHE II score at diagnosis was the only independent factor found to assist in the prognosis of mortality for patients in the ICU with an A. baumannii infection. In conclusion, the results of the present study demonstrated that the APACHE II score may contribute towards the prognostic evaluation of patients in the ICU with an A. baumannii infection.
Keywords: Acinetobacter baumannii; critically ill patients; prognosis; retrospective analysis.
Figures
Similar articles
-
[Lactic acid, lactate clearance and procalcitonin in assessing the severity and predicting prognosis in sepsis].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):449-453. doi: 10.3760/cma.j.cn121430-20200129-00086. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32527351 Chinese.
-
[The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Aug;28(8):688-93. doi: 10.3760/cma.j.issn.2095-4352.2016.08.004. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016. PMID: 27434557 Chinese.
-
Microbiological characteristics and risk factors on prognosis associated with Acinetobacter baumannii bacteremia in general hospital: A single-center retrospective study.Front Microbiol. 2022 Nov 10;13:1051364. doi: 10.3389/fmicb.2022.1051364. eCollection 2022. Front Microbiol. 2022. PMID: 36439789 Free PMC article.
-
[Prognostic value of Charlson weighted index of comorbidities combined with sequential organ failure assessment score and procalcitonin in patients with sepsis].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Nov;31(11):1335-1339. doi: 10.3760/cma.j.issn.2095-4352.2019.11.005. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31898562 Chinese.
-
[Predictive value of four different scoring systems for septic patient's outcome: a retrospective analysis with 311 patients].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Feb;29(2):133-138. doi: 10.3760/cma.j.issn.2095-4352.2017.02.008. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28625260 Chinese.
Cited by
-
Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon.Antimicrob Resist Infect Control. 2023 Nov 29;12(1):136. doi: 10.1186/s13756-023-01343-8. Antimicrob Resist Infect Control. 2023. PMID: 38031181 Free PMC article.
-
Analysis of Lung Microbiome in COVID-19 Patients during Time of Hospitalization.Pathogens. 2023 Jul 17;12(7):944. doi: 10.3390/pathogens12070944. Pathogens. 2023. PMID: 37513791 Free PMC article.
-
Molecular epidemiology of Acinetobacter baumannii complex causing invasive infections in Korean children during 2001-2020.Ann Clin Microbiol Antimicrob. 2023 May 3;22(1):32. doi: 10.1186/s12941-023-00581-3. Ann Clin Microbiol Antimicrob. 2023. PMID: 37138308 Free PMC article.
-
Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology.Antibiotics (Basel). 2023 Mar 4;12(3):516. doi: 10.3390/antibiotics12030516. Antibiotics (Basel). 2023. PMID: 36978383 Free PMC article. Review.
-
Carbapenem-Resistant Acinetobacter baumannii: Biofilm-Associated Genes, Biofilm-Eradication Potential of Disinfectants, and Biofilm-Inhibitory Effects of Selenium Nanoparticles.Microorganisms. 2023 Jan 10;11(1):171. doi: 10.3390/microorganisms11010171. Microorganisms. 2023. PMID: 36677463 Free PMC article.
References
-
- García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Pérez-Paredes C, Barrero-Almodóvar AE, Gili-Miner M. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: A cohort study. Clin Infect Dis. 2001;33:939–946. doi: 10.1086/322584. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources